The development and feasibility of a composite score of echocardiographic indices that may stratify outcome in patients with diabetes mellitus.

Pubmed ID: 25577772

Journal: International journal of cardiology

Publication Date: March 1, 2015

Affiliation: Department of Statistics, University of Auckland, Private Bag 92019, Auckland, New Zealand.

MeSH Terms: Humans, Male, Female, Aged, Risk Factors, Risk Assessment, Proportional Hazards Models, Heart Failure, Follow-Up Studies, Ventricular Dysfunction, Left, Diabetes Mellitus, Type 2, Echocardiography, Feasibility Studies, New Zealand

Authors: Patel A, Woodward M, Doughty RN, Poppe KK, Whalley GA, Triggs CM, Chow CK, Hirakawa Y, Chalmers J, Hillis GS

Cite As: Poppe KK, Whalley GA, Doughty RN, Woodward M, Patel A, Chow CK, Hirakawa Y, Chalmers J, Hillis GS, Triggs CM. The development and feasibility of a composite score of echocardiographic indices that may stratify outcome in patients with diabetes mellitus. Int J Cardiol 2015 Mar 1;182:244-9. Epub 2014 Dec 27.

Studies:

Abstract

BACKGROUND: Early detection of changes in cardiac structure and function associated with type 2 diabetes (T2DM) is important. However when multiple abnormalities are present, combining individual measurements can be subjective. This study sought to create a simple echo score that summarises measurements that may detect early and prognostically important changes in cardiac function. METHODS: Standard echocardiography was performed on 849 people with T2DM (median age 65years, 40% female, median duration of diabetes 5.5years). Principal components analysis was performed on measurements of LV mass, LA volume, E:e', and s', to create an objective summary score. The score was included in two Cox proportional hazard models adjusted for CV risk factors: one estimated the development of heart failure (HF) and the second estimated any CV event. RESULTS: The first two principal components represented 75% of the variation between the four echo measurements. A continuous score that represents the residual difference between these two components was derived that only requires measurement of medial E:e' and s'. The score was significantly associated with the development of HF within four years (hazard ratio 1.34; 95% CI 1.15, 1.56). CONCLUSIONS: We have developed a simple, objective score that enhances the use of echocardiography in the detection of sub-clinical cardiac disease in people with T2DM. Initial findings suggest that it may help identify those at increased risk of developing HF within four years.